DOI:
10.1055/s-00046370
Global Medical Genetics
LinksClose Window
References
Li D, Yuan H, Ortiz-Gonzalez XR. , et al.
GRIN2D recurrent de novo dominant mutation causes a severe epileptic encephalopathy treatable with NMDA receptor channel blockers.
Am J Hum Genet 2016;
99 (04) 802-816
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.